-
-
-
-
-
-
-
AMGEN presents data on rare disease drugs at european medical congress
-
-
-
-
-
-
-
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
-
-
-
-
-
-
-
RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'
-
-
-
-
-
-
-
Amgen expands direct-pay program, cuts drug prices up to 80%
-
-
-
-
-
-
-
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
-
-
-
-
-
-
-
FDA approves TEZSPIRE for chronic rhinosinusitis with nasal polyps
-
-
-
-
-
-
-
Amgen plans $650 million manufacturing expansion, creating 750 jobs
-
1,173,532 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

